Yi‐Ting Tsai

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 2.8K citations · Full text

Metabolic Syndrome, Diabetes Management, Cardiovascular Disease +9

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 600 citations · Full text

Metabolic Syndrome, Diabetes Management, Urology +10

Long-term Safety and Efficacy of Human-Induced Pluripotent Stem Cell (iPS) Grafts in a Preclinical Model of Retinitis Pigmentosa

Yao Li, Yi‐Ting Tsai, Chun‐Wei Hsu et al. · Molecular Medicine · 2012 · 164 citations · Full text

Extracorporeal membrane oxygenation for refractory cardiogenic shock after cardiac surgery: predictors of early mortality and outcome from 51 adult patients

Po-Shun Hsu, Jialin Chen, Guo-Jieng Hong et al. · European Journal of Cardio-Thoracic Surgery · 2009 · 146 citations · Full text

Clustered Regularly Interspaced Short Palindromic Repeats-Based Genome Surgery for the Treatment of Autosomal Dominant Retinitis Pigmentosa

Yi‐Ting Tsai, Wen-Hsuan Wu, Ting-Ting Lee et al. · Ophthalmology · 2018 · 119 citations

Chromatin, Genome Surgery, Ophthalmology +5